FDA Staff Contemplate How to Manage RFK Jr., Including the Option of Resigning

Some staff members at the FDA are considering leaving if Robert F. Kennedy Jr. is appointed to a health role in the incoming Trump administration, according to government officials. Staff turnover is common during transitions, but concerns are heightened with Kennedy’s potential appointment. Kennedy has promised a shakeup at federal health agencies, including the FDA. The FDA commissioner expressed uncertainty about the agency’s future under the new administration. Trump’s plan to end the revolving door for lobbying officials is also causing concern among staff about their job prospects. Some employees are up for retirement and may see this as an opportune time to leave. It is uncertain what role Kennedy will have in the administration and how much influence he will have over the FDA. Trump’s administration previously considered having Kennedy spearhead an initiative related to childhood chronic diseases. Overall, there is uncertainty among FDA staff about what the future holds under the new administration and who will be appointed to key positions.

Photo credit
www.nbcnews.com